Introduction {#dmy021s6}
============

All cell types of an organism contain identical genetic information and yet are distinct in function and characteristics. Instructive epigenetic marks are key to this developmental conundrum. Epigenetic marks include modifications to the DNA or its associated proteins, which enable regulation of gene expression in a cell type-specific manner (Fig. [1](#dmy021F1){ref-type="fig"}). Among the most well-characterised epigenetic modifications is DNA methylation, but the various additional layers of epigenetic information may represent more dynamic and responsive features of this regulation landscape. DNA is wrapped around an octamer of histone proteins (a nucleosome) enabling its compaction and organisation in the nucleus. Numerous post-translational modifications and/or variants of these histone proteins can facilitate the packaging of chromatin into accessible or inaccessible states and, consequently, regions of active or repressed gene expression, respectively.

![Levels of epigenetic regulation. The DNA sequence can be methylated at cytosine residues in a CpG context, termed DNA methylation. DNA is wrapped around the histone octamer to form the nucleosome. Variants and post-translational modifications of these histone proteins form another layer of epigenetic regulation. The state of these epigenetic modifications together determines whether the chromatin will be organised in an accessible 'open' or an inaccessible 'closed' state. Higher order folds and loops organise the chromatin into active and inactive compartments.](dmy021f01){#dmy021F1}

The field of developmental biology has long studied the intriguing nature of how two fully differentiated and very distinct cells, the sperm and the oocyte, can come together to create a totipotent embryo. Genetic studies in mice have firmly established that epigenetic regulation is key to the acquisition of totipotency during this transition. Early studies using molecular approaches and immunofluorescence showed that widespread epigenetic reprogramming accompanies both germ cell and embryonic development ([@dmy021C174]; [@dmy021C176]). However, limitations in obtaining large numbers of cells, specifically in oogenesis and early embryogenesis, has restricted the detailed molecular investigation in these cells, until recently. Advances in low-input and single-cell sequencing methods have not only improved our understanding of these developmental windows, but the data have also led to new questions and challenged existing dogmas/hypotheses. In this review, we summarise the current knowledge of epigenetic dynamics in development, from DNA methylation to chromosome organisation, specifically during spermatogenesis, oogenesis, pre-implantation development and early lineage specification. We will discuss how the mechanistic insights established in mice may be relevant for human development and reflect on known differences between the two systems. In this review, we focus particularly on the recent developments in *in-vivo* studies.

Recent advances in epigenetic profiling technologies {#dmy021s7}
====================================================

Next generation sequencing based approaches have revolutionised our ability to profile epigenetic information and all layers of the epigenome can now be interrogated by these methods. Until relatively recently, these technologies have required millions of cells to obtain high resolution genomic maps, but advances in capturing and amplifying smaller and smaller amounts of material have allowed them to be scaled down to require only minimal numbers of cells (Table [I](#dmy021TB1){ref-type="table"}). Table ILow-input and single cell methods available for assaying epigenetic modifications.Epigenetic layerAssayLow-cell protocolSingle-cell protocolDNA methylationPost-bisulfite adaptor tagging (PBAT)400 cells ([@dmy021C136])Yes ([@dmy021C185])Reduced representation bisulfite sequencing (RRBS)75--1000 cells ([@dmy021C184])Yes ([@dmy021C79])Histone modificationsChromatin immunoprecipitation (ChIP)-seq400--1000 cells ([@dmy021C28], [@dmy021C222], [@dmy021C45], [@dmy021C88]Yes\* ([@dmy021C167])Cleavage under targets and release using nuclease (CUT&RUN)100 cells ([@dmy021C183])Not availableChromatin accessibilityAssay for transposase accessible chromatin (ATAC)-seq20--100 cells ([@dmy021C209], [@dmy021C210]Yes ([@dmy021C31]; [@dmy021C44]DNase-seq100--200 cells ([@dmy021C121])Yes ([@dmy021C100])DNA methylation and chromatin accessibilityNucleosome occupancy and methylome (NOMe)-seqNot availableYes ([@dmy021C159], [@dmy021C77], [@dmy021C39]Higher order organisationHi-C500 cells ([@dmy021C55])Yes ([@dmy021C142])[^2]

DNA methylation can be studied with greatest resolution and precision by bisulphite conversion followed by sequencing ([@dmy021C41]). Bisulphite treatment converts the DNA base cytosine to uracil, but only when the cytosine is unmethylated. In this manner, methylated and unmethylated cytosines can be distinguished by sequencing. Bisulphite sequencing initially required large amounts of starting material because the bisulphite conversion reaction leads to DNA breaks and loss of material. This problem has been overcome by refinements in methods such as post bisulphite-adaptor tagging (PBAT) and reduced representation bisulphite (RRBS) sequencing, which allow the interrogation of DNA methylation in just 100--200 cells or even on a single-cell level ([@dmy021C136]; [@dmy021C184]; [@dmy021C79]; [@dmy021C185]). Methods independent of bisulphite chemistry may provide alternatives that circumvent the loss of material inherent in bisulphite treatment ([@dmy021C21]). A variety of approaches have also been developed to map oxidation derivatives of 5-methylcytosine, some at the single-cell level, but they typically lack the sensitivity or absolute quantification of bisulphite sequencing ([@dmy021C108]).

Histone proteins can be post-translationally modified at numerous amino acid residues in the protruding N-terminal tail or core domain ([@dmy021C223]); these predominantly include methylation, acetylation, phosphorylation and ubiquitination. Using antibodies, the abundance and nuclear distribution of these modification states have been studied by immunofluorescence and Western blots. Determining their genomic occupancy depends upon using antibodies to precipitate chromatin fragments (chromatin immunoprecipitation, ChIP) followed by purification of the associated DNA. In 2006, next-generation sequencing was applied for the first time to obtain genome-wide maps of histone modifications, in a method termed ChIP-seq ([@dmy021C15]; [@dmy021C133]; [@dmy021C163]). This method is an enrichment-based approach that is strongly dependent on antibody efficiency and specificity. Only recently, ChIP-seq has been adapted for low-cell inputs of 500--1000 cells ([@dmy021C28]; [@dmy021C45]; [@dmy021C222]; [@dmy021C88]), and single-cell approaches still require the processing of thousands of individual cells ([@dmy021C167]). A novel approach, termed cleavage under targets and release using nuclease (CUT&RUN), has been developed to allow the evaluation of histone modification patterns in as few as 100 cells ([@dmy021C183]). CUT&RUN involves tethering a DNA-cutting enzyme to a histone-bound antibody, resulting in only targeted DNA-wrapped nucleosomes being released into solution for sequencing ([@dmy021C183]).

Chromatin states can be analysed further by a variety of methods that use enzymes to isolate accessible from inaccessible regions of DNA. For example, the assay of transposase-accessible chromatin (ATAC-seq) employs the Tn5 transposase to integrate sequencing adapters into regions of accessible chromatin ([@dmy021C30]), while DNase-seq employs the DNase I enzyme to cleave these regions ([@dmy021C25]). Both methods have recently been adapted for single-cell and low-cell input ([@dmy021C31]; [@dmy021C44]; [@dmy021C100]; [@dmy021C121]; [@dmy021C209]). An alternative assay, termed nucleosome occupancy and methylome (NOMe-seq), uses a unique non-enrichment-based approach to evaluate chromatin accessibility, by exploiting a bacterial methyltransferase ([@dmy021C107]). Accessible regions of DNA are demarked with GpC methylation, and therefore subsequent bisulphite sequencing not only provides information on DNA accessibility but additionally endogenous DNA methylation patterns. NOMe-seq has been successfully adapted to the single-cell level ([@dmy021C159]; [@dmy021C77]; [@dmy021C39]).

On a larger scale, chromatin conformation capture (Hi-C) methods evaluate chromosome interactions from a defined loci or throughout the nucleus, using cross-linking to ligate regions of DNA that lie in close proximity to each other ([@dmy021C118]). The so-called topological associated domains (TADs) partition the genome into large self-interacting A (active) and B (silent) compartments. Hi-C sequencing can also be conducted on a single-cell level ([@dmy021C142]), but at rather limited resolution. At higher resolution, HiC-based methods can identify enhancer-promoter interactions, but this application is not yet possible in low numbers of cells.

Epigenetic regulation of gene expression {#dmy021s8}
========================================

In differentiated cells, there are canonical patterns of epigenetic marks across genomic elements (Fig. [2](#dmy021F2){ref-type="fig"}). DNA methylation is generally high across gene bodies and inter-genic regions, with low or intermediate methylation observed almost exclusively at regulatory regions, such as promoters and enhancers. Histone marks, typified by histone H3 modifications, also show reproducible genomic patterns, some of which are correlated with gene expression. Active marks, such as histone 3 lysine 4 trimethylation (H3K4me3) and/or histone 3 lysine 27 acetylation (H3K27ac), are found at active promoters and/or enhancers, are negatively correlated with DNA methylation, and positively correlated with gene expression (Fig. [2](#dmy021F2){ref-type="fig"}) ([@dmy021C189]). Repressive histone marks, such as H3K36me3 across transcribed gene bodies and H3K9me2 and/or H3K9me3, are strongly associated with DNA methylation and transcriptional silencing ([@dmy021C54]). While gene body H3K36me3 is positively correlated with transcription, paradoxically it is thought to function across gene bodies by repressing spurious, off-target transcription initiation ([@dmy021C145]) and promoting acquisition of DNA methylation ([@dmy021C17]). Alternatively, while repressive H3K27me3 is associated with transcriptional silencing, it is predominantly localised with unmethylated DNA, suggesting it may be complementary mode of genomic silencing (Fig. [2](#dmy021F2){ref-type="fig"}) ([@dmy021C124]). While many other modifications of histone proteins have been reported ([@dmy021C223]), in this review we focus on the aforementioned well-characterised histone modifications.

![Canonical epigenetic patterns. H3K4me3 is associated with actively transcribed promoters, as well as CpG islands, irrespective of transcription. H3K27ac demarks active promoters and enhancers, while associated transcribed genes bodies are enriched for H3K36me3. Repressed regions of the genome are typically associated with either H3K9me2/3 or H3K27me3. DNA is generally highly methylated throughout the genome, with the exception of regulatory regions marked by H3K4me3 and/or H3K27ac, and H3K27me3- domains. Methylated CpGs are depicted as closed circles and unmethylated CpGs are open circles.](dmy021f02){#dmy021F2}

DNA methylation is established and maintained by a protein family of five DNA methyltransferases (DNMTs). Among these, three *de-novo* DNMTs (DNMT3A, 3B and 3C) and a catalytically inactive co-factor (DNMT3L) are responsible for establishing cytosine methylation, usually in a CpG context ([@dmy021C152]; [@dmy021C24]; [@dmy021C14]). It is not fully apparent how DNA methylation is targeted to specific regions of the genome, but biochemical studies have shown that several domains on the DNMT proteins or their co-factors can interact with modified histone tails ([@dmy021C153]; [@dmy021C49]). During cell replication, DNMT1 is localised to hemi-methylated DNA at the replication fork by the co-factor UHRF1 ([@dmy021C22]; [@dmy021C179]), where it faithfully copies CpG methylation patterns to the newly replicated DNA strand ([@dmy021C116]). Once established, DNA methylation can be repressive for transcription either by impairing the binding of transcription factors or through the activity of methyl-binding proteins ([@dmy021C90]; [@dmy021C52]). Classic examples of the repressive role for DNA methylation are X-chromosome inactivation in females and imprinted gene regulation, where one parental allele is silenced through the inheritance of differential germline methylation ([@dmy021C101]). Methylated cytosine can be oxidised to the derivatives 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine through the action of Ten-Eleven Translocation (TET) proteins, but whether these derivatives function as epigenetic marks in a manner similar to 5-methylcytosine is not clear ([@dmy021C211]).

The modifications of histone tails are dynamically regulated by so-called 'writers' and 'erasers', and once established can be bound by 'readers' ([@dmy021C36]; [@dmy021C168]; [@dmy021C199]; [@dmy021C2]). There is an ever-growing list of proteins that can modulate and/or bind histones (<http://weram.biocuckoo.org/>), suggesting that the complexity of this system is extensive. In general terms, active and repressive histone marks, through their respective readers, can enable the immediately surrounding chromatin to be packaged in an open (accessible) or closed (inaccessible) conformation, respectively ([@dmy021C220]). Regions of open or closed chromatin are organised into self-interacting compartments, termed TADs, which are on average \~1 Mb in size ([@dmy021C50]). Within the nucleus, TADs of similar chromatin conformation are more likely to organise together into active and inactive (A and B) compartments ([@dmy021C118]). This supports the notion that there is coordinate regulation of transcriptional activity through the 3D organisation of DNA within the nucleus.

Ongoing work in model systems including, but not limited to, the mouse is building our understanding of the interplay between these epigenetic layers and how they coordinate genomic regulation. One way to evaluate these relationships is to study their dynamics during developmental reprogramming and lineage specification, an area of research that has rapidly advanced in the past few years.

Mechanistic insights from mouse models {#dmy021s9}
======================================

Gametogenesis {#dmy021s10}
-------------

The chromatin organisation and epigenetic profiles of the male and female gametes at the time of fertilisation are profoundly different. Sperm DNA is highly methylated and tightly packaged with protamines, a protein that replaces canonical histones ([@dmy021C208]); while oocyte DNA is uniquely methylated in an bimodal pattern and is associated with non-canonical distributions of histone modifications ([@dmy021C196]) (Fig. [3](#dmy021F3){ref-type="fig"}). These divergent patterns are established during gametogenesis, which is initiated during embryonic development. The precursors for both male and female germ cells are assigned in the epiblast at embryonic day (E) 7.25 and as these primordial germ cells (PGCs) migrate to the genital ridge (E9.5--E11.5), they undergo almost complete demethylation of the genomic DNA ([@dmy021C75]; [@dmy021C176]). The loss of DNA methylation is due to downregulation of both *de-novo* DNMTs and the DNMT1-cofactor UHRF1 ([@dmy021C103]). With the decline of DNA methylation, there is a re-organisation of repressive histone marks as well, with widespread loss of H3K9me2 and an increase of H3K27me3 ([@dmy021C177]). PGCs then subsequently progress either into spermatogenesis or oogenesis, depending on the sex of the embryo.

![Epigenetic reprogramming in mouse development. (**A**) Epigenetic patterns are shown for non-growing oocytes and fully grown germinal vesicle (GV) oocytes. In non-growing oocytes, DNA is almost completely unmethylated, H3K4me3 is exclusively enriched at active promoters and H3K27me3 is spanning broad non-canonical domains. By the fully grown GV stage, DNA across transcribed gene bodies is fully methylated and H3K4me3 has accumulated in broad domains throughout untranscribed regions. (**B**) Schematic of epigenetic reprogramming events during gametogenesis and embryogenesis. DNA methylation is erased in primordial germ cells and re-established earlier in the sperm of males and after birth in oocytes in females. Oocytes acquire lower overall methylation than sperm, with non-canonical genome-wide distribution. After fertilisation, the paternal DNA is rapidly demethylated, while maternal DNA methylation is passively lost over several cell divisions. DNA methylation is re-acquired in canonical patterns in the post-implantation embryo, concomitant with lineage specification. H3K4me3 is non-canonically distributed in the oocyte, is rapidly erased after fertilisation, and becomes canonically enriched at CpG islands and active promoters. Very few domains retain H3K4me3-marked histones in the protamine exchange in sperm and subsequently through the re-acquisition of histones in the zygote. H3K27me3 acquires a non-canonically broad distribution in PGCs in the absence of other repressive epigenetic marks. This pattern is relatively maintained throughout oogenesis, while very few H3K27me3-marked histones are retained in the sperm protamine exchange. In the pre-implantation embryo, H3K27me3-transmitted from the gametes is progressively lost, with pronounced loss at CpG-rich regions. H3K27me3 is then re-established in a canonical pattern in the post-implantation embryo. Chromatin accessibility is contrastingly and exceptionally open in the oocyte and compact in the sperm. The open chromatin state of maternal DNA is gradually resolved in the pre-implantation embryo, while the compact packaging of paternal DNA is rapidly resolved with incorporation of histones in the zygote. Topological associated domains (TADs) are nearly absent in the mature oocyte and become gradually re-instated in the pre-implantation embryo.](dmy021f03){#dmy021F3}

In early sperm progenitors (prospermatogonia), DNA methylation begins to be re-established before birth (E15.5--E18.5) and is completed at the termination of meiotic pachytene after birth (D10--19) ([@dmy021C81]) (Fig. [3](#dmy021F3){ref-type="fig"}). DNA methylation is essential for meiotic progression ([@dmy021C23]). Methylation of sperm DNA broadly resembles other cell types in that it is almost uniformly methylated with the exception of regulatory regions. While the DNA is initially wrapped around histones in spermatocytes, the vast majority of histones are replaced, first with non-canonical histone variants and transition proteins, which are subsequently replaced with protamines during maturation, allowing the DNA to be tightly packaged into the compact sperm head ([@dmy021C11]; [@dmy021C13]). The functional relevance of the \~1% of histones that are retained in mature sperm is still debated. It seems that at least a subset of these histones reside at CpG-rich promoters with low DNA methylation, although it has been suggested that the vast majority are retained in gene poor regions ([@dmy021C58]; [@dmy021C34]). Residual histones in sperm support the possibility of intergenerational or possibly transgenerational inheritance of an intrinsic epigenetic memory programme through the male germline. Indeed, loss of H3K4me2 in sperm caused by forced expression of an H3K4-demethylase has been shown to impair the viability of offspring in subsequent generations ([@dmy021C182]).

Shortly after the migration of germ cells to the gonad in females, there is massive mitotic expansion of this germ cell pool (E11.5). At E13.5, these oocyte precursors enter meiotic arrest in prophase I and remain quiescent in the developing ovary until after birth when they are assembled into primordial follicles. These cells represent the oocyte pool for the female's entire lifespan, only a small subset of which will ever become fully mature and ovulate, as the vast majority will undergo apoptosis.

During folliculogenesis, oocytes undergo *de-novo* DNA methylation in the phase of oocyte growth ([@dmy021C92]), mediated by the *de-novo* DNA methyltransferases DNMT3A and cofactor DNMT3L ([@dmy021C24]; [@dmy021C105]) (Fig. [3](#dmy021F3){ref-type="fig"}). Unlike the highly methylated sperm, oocyte methylation is distinctly located over transcribed gene bodies ([@dmy021C110]; [@dmy021C201]) in a pattern that is unique among mammalian cell types. The acquisition of DNA methylation across transcribed regions has been suggested to be dependent on the modification of associated histones, including acquisition of H3K36me3 and exclusion of H3K4me3 by H3K4 demethylases KDM1A/B ([@dmy021C190]; [@dmy021C66]). DNMT1 and UHRF1 are required to complete *de-novo* methylation, which is unusual as this protein complex normally functions in the context of maintenance methylation ([@dmy021C181]; [@dmy021C123]). Oocytes also have unusually high levels of methylation of cytosines outside of a CpG context. The functional significance of this 'non-CpG' methylation is unclear and may merely reflect the protracted period during which the *de-novo* methyltransferases are active ([@dmy021C196]; [@dmy021C181]). Curiously, DNA methylation in general has no obvious function in oocytes, as loss of DNA methylation through conditional deletion of *Dnmt3a* or *Dnmt3L* has no effect on oogenesis ([@dmy021C105]; [@dmy021C24]).

Intriguingly, across the unmethylated fraction of the oocyte genome, histone modification patterns are also non-canonical in their distribution. A histone mark typically associated with active promoters, H3K4me3, accumulates in a transcription-independent manner at unusually broad, inter-genic domains ([@dmy021C45]; [@dmy021C222]; [@dmy021C88]) (Fig. [3](#dmy021F3){ref-type="fig"}). This non-canonical pattern of H3K4me3 has been attributed to the activity of a single H3K4 methyltransferase, MLL2 and appears to be, at least partially, driven by underlying CpG density ([@dmy021C88]). Paradoxically, acquisition of non-canonical domains of H3K4me3 appears to be required for genome-wide transcriptional silencing associated with oocyte maturation and resumption of meiosis ([@dmy021C6]; [@dmy021C45]; [@dmy021C222]). Repressive H3K27me3, is also found broadly throughout unmethylated genomic regions and appears to be actively excluded from transcribed regions throughout oogenesis ([@dmy021C224]) (Fig. [3](#dmy021F3){ref-type="fig"}). The role of H3K27me3 in oogenesis is not clear, but it appears to be required to establish a non-canonical form of imprinting in the early embryo ([@dmy021C95]), discussed in more detail below.

The oocyte also has a very distinct chromosome architecture compared to other cell types. Chromatin undergoes major conformational changes during the final stages of maturation in the germinal vesicle (GV) oocyte, from a non-surrounded nucleolar-like body (NSN) to a surrounded (SN) state ([@dmy021C127]; [@dmy021C227]) accompanying transcriptional silencing. In GV oocytes, Hi-C studies have found chromosome interactions such as TADs and chromosome loops, but the strength of these interactions begin to decrease as the oocytes progress through the NSN to SN transition ([@dmy021C61]). With resumption of meiosis, oocytes appear to lose all higher-order chromatin structures, such that metaphase II (MII) oocytes show a uniform interaction pattern along entire chromosomes that appears to be locus independent ([@dmy021C106]; [@dmy021C55]).

The distinct epigenetic patterns observed in the oocyte suggest that there may be an uncoupling of some of the conventional mechanisms of gene regulation. This uncoupling might be a requirement to allow the oocyte to maintain necessary gene regulation, while simultaneously establishing an epigenome capable of facilitating the early events of embryogenesis.

From germ cells to the embryo {#dmy021s11}
-----------------------------

In the zygote, the maternal and paternal genomic contributions are reprogrammed distinctively and these dynamics are required for the acquisition of totipotency and zygotic genome activation (ZGA). Immediately after fertilisation, the paternal protamines are replaced by maternal histones accompanied by widespread erasure of almost all paternal DNA methylation. This was proposed to be active demethylation mediated through TET activity ([@dmy021C74]; [@dmy021C97]), but recent data challenges this finding ([@dmy021C3]) and thus the mechanism of this initial erasure remains unresolved ([@dmy021C91]). Conversely, maternal DNA methylation is largely preserved at this stage. However, it does appear that the widespread, non-canonical maternal H3K4me3 needs to be reprogrammed in order for the embryo to initiate ZGA and this occurs through activity of H3K4 demethylases KDM5B and KDM1A ([@dmy021C222]; [@dmy021C45]; [@dmy021C4]).

Long-range and local chromosome interactions are not immediately restored in the post-meiotic zygote, as is the case for mitotic cells. Intriguingly, re-establishment of higher-order chromatin structure occurs independently of ZGA and cell cycle, suggesting that additional factors are required for re-establishing these interactions ([@dmy021C55]). Chromosome compartmentalisation in zygotes is associated with DNA methylation, chromatin accessibility and H3K27me3, but not broad maternal H3K4me3 ([@dmy021C106]).

As the embryo develops towards the blastocyst stage, DNA methylation is passively lost from both the maternal and paternal genomes, resulting in the erasure of most gametic DNA methylation. There are a few thousand domains that are protected from this erasure; these include, but are not limited to, imprinted domains and some classes of repetitive elements ([@dmy021C186]). Similar to DNA methylation, repressive H3K27me3 also appears to be progressively lost during pre-implantation development, with maternal H3K27me3 being preferentially retained at distal, inter-genic regions ([@dmy021C224]). The mechanism for preferential loss or retention of maternal H3K27me3 at specific loci remains unclear. In *Drosophila*, maternally inherited H3K27me3 regulates the activation of enhancers in the early embryo ([@dmy021C219]). Considering the correlation between compartmentalisation, chromatin accessibility and H3K27me3 ([@dmy021C106]), loss of H3K27me3 may also be required for the establishment of promoter--enhancer interactions in mammalian pre-implantation development. H3K9 di- and tri-methylation are repressive histone modifications that are tightly associated with DNA methylation and are bound by heterochromatin protein 1 (HP1) ([@dmy021C12]; [@dmy021C113]); however, there is currently no molecular data evaluating the dynamics of H3K9 methylation in oocytes or early embryogenesis. Immunofluorescence shows that H3K9me3, typically associated with silenced repetitive DNA, is predominantly inherited at maternal peri-centromeres in the early embryo ([@dmy021C160]). As the paternal chromatin structure is newly re-established with the re-integration of histones, the peri-centromeres are first silenced by H3K7me3 and by the 8-cell stage similarly acquire H3K9me3 ([@dmy021C160]). In addition to these repetitive regions, H3K9me2 and H3K9me3 may be required to maintain silencing and protect parental DNA methylation at imprinted domains ([@dmy021C143]; [@dmy021C161]), as discussed in more detail below. Future characterisation of the genomic distribution of H3K9me2/3 will be essential to determine the role for these marks in early gene regulation and protection of germline DNA methylation.

In addition to DNA methylation and histone remodelling in pre-implantation development, chromatin structure appears to be progressively re-organised. ATAC-seq ([@dmy021C209]) and Hi-C experiments ([@dmy021C55]; [@dmy021C61]; [@dmy021C106]) showed that zygotes have a very relaxed chromatin state, which is gradually resolved to a more canonical state by the blastocyst stage, a finding that is consistent with previous microscopy-based observations ([@dmy021C1]; [@dmy021C32]). With the re-establishment of higher-order chromatin structure in the pre-implantation embryo, interactions between promoters and enhancers become defined ([@dmy021C55]; [@dmy021C106]) and the number of DNase hypersensitivity sites increases ([@dmy021C121]).

Together, the epigenetic profiles explored to date in pre-implantation embryos demonstrate that the chromatin regulatory landscape is dynamic during the transition from a totipotent to a pluripotent embryo with refinement of chromatin compartments and localisation of H3K4me3 to promoters. Paradoxically, this transition is accompanied by almost widespread loss of repressive DNA methylation and H3K27me3, suggesting that targeting of transcriptional machinery in pre-implantation embryo is not facilitated by these protective repressive marks.

Lineage specification in post-implantation development {#dmy021s12}
------------------------------------------------------

Once the embryo implants, there are widespread morphological changes as cell lineages differentiate, accompanied by epigenetic programming. The role of epigenetic regulation during this lineage specification is complex and still not fully understood. Many studies investigating epigenetic mechanisms in lineage specification thus far have used transgenic mouse models to identify key regulators; *in-vivo* data showing the localisation and dynamics of epigenetic modifications remain scarce.

There is substantial evidence for a function for repressive chromatin marks in reinforcing lineage specification. During post-implantation development, there is *de-novo* acquisition of repressive DNA methylation ([@dmy021C152]), H3K9me2 ([@dmy021C228]) and H3K27me3 ([@dmy021C224]), all of which are essential for appropriate lineage development. Genetic ablation in mice of the H3K27 methyltransferase EZH2 ([@dmy021C149]), H3K9 methyltransferase EHMT2 (also known as G9A) ([@dmy021C192], [@dmy021C193]) or *de-novo* DNA methyltransferase DNMT3B ([@dmy021C152]) all lead to developmental abnormalities and lethality in mid-gestation.

In the post-implantation embryo, repressive H3K27me3 is targeted *de novo* to transcriptionally silent promoters, including CpG islands, and gene bodies, by Polycomb repressive complex proteins ([@dmy021C119]; [@dmy021C224]) and is required to keep these genes transcriptionally repressed at this stage ([@dmy021C215]). This programming corresponds to a widespread switch from the maternally inherited enrichment pattern at silent inter-genic B compartments in the pre-implantation embryo to the regulatory domains of active A compartments in the post-implantation embryo ([@dmy021C224]; [@dmy021C106]). At many regulatory domains, H3K27me3 can be found together with H3K4me3 in a chromatin state referred to as bivalent. Bivalent domains are enriched at unmethylated, but silent, promoters of developmental genes in the post-implantation epiblast and extra-embryonic ectoderm ([@dmy021C170]). Bivalent chromatin is thought to poise these genes for rapid activation or repression during lineage specification in the developing embryo ([@dmy021C18]). Indeed, it has been shown during migration and development of neural crest cells that bivalent genes are embedded in large repressive Polycomb domains in which they maintain plasticity and chromatin accessibility in all subpopulations ([@dmy021C135]). Upon differentiation, decreasing H3K27me3 and increasing H3K4me2 then leads to cell type-specific gene expression ([@dmy021C135]). While the genomic location and resolution of bivalent domains has now been characterised *in vivo* ([@dmy021C135]; [@dmy021C224]), paralleling the observations made in cultured cells, it remains unclear how H3K27me3 is targeted in the post-implantation embryo.

Unlike the targeted gain of H3K27me3 in the post-implantation embryo, DNA methylation is established across \~80% of the embryonic genome. Yet despite its widespread occurrence, DNA methylation does not appear to be necessary to direct the transcriptional programme in early embryos, but rather to reinforce lineage decisions ([@dmy021C221]). As such, there are a few key domains that become differentially methylated between the post-implantation embryonic and extra-embryonic compartments to prevent aberrant trans-differentiation ([@dmy021C146]; [@dmy021C221]). Similarly, differential methylation was observed at functionally relevant enhancer elements between gastrulating tissues, suggesting that this mechanism may also reinforce lineage commitment within the embryo ([@dmy021C221]).

Interestingly, despite dramatic acquisition of H3K9me2 in post-implantation development, it is not required for the genome-wide gain of DNA methylation, but rather appears to be important for a small subset of CpG-rich domains ([@dmy021C9]). As such, deposition of H3K9me2 is only necessary for efficient repression of a few germline-specific genes, mediated by silencing of their promoters and/or enhancers ([@dmy021C228]; [@dmy021C9]). Furthermore, H3K9me2 deposited by EHMT2 is not required for silencing the vast majority of repetitive elements ([@dmy021C228]). Together these findings suggest that H3K9me2 is ubiquitously associated with methylated DNA in the post-implantation embryo, but its functional role is rather specialised. This may be attributable to redundancies in repressive epigenetic marks or to these repressive modifications acting not as upstream transcriptional regulators but rather as reinforcements for transcriptionally inactive regions of DNA.

Active chromatin marks, such as H3K4me3 and H3K27ac, also likely play a role in transcriptional regulation during lineage specification. Active histone modifications can promote transcription by facilitating the accessibility of regulatory regions to transcription factors, but whether these marks are required for establishing a transcriptional programme or for merely reinforcing it remains contentious ([@dmy021C94]). For example, the level of H3K4me3 at promoters correlates with transcription and transcriptional machinery interacts with H3K4me3; however, in many contexts, ablation of H3K4me3 has a limited effect on transcription ([@dmy021C27]; [@dmy021C40]; [@dmy021C125]). The predominant H3K4 methyltransferase in the pre-implantation embryo is MLL2, while in the post-implantation embryo it is SETD1A ([@dmy021C20]). However, due to the overlapping redundancy of the six H3K4 methyltransferase proteins, it has been challenging to interpret the role for each methyltransferase and, in turn, H3K4me3 during embryogenesis ([@dmy021C20]). Embryos deficient in H3K4 methyltransferases MLL1 and MLL2 both arrest in mid-gestation and show patterning defects likely due to aberrant expression levels of a subset of the *Hox* genes ([@dmy021C59]; [@dmy021C72]), suggesting that MLL1/2-mediated H3K4me3 is required to express appropriate levels of these genes. The post-implantation upregulation of SETD1A appears to have a central role in lineage specification, as it is required to complete gastrulation ([@dmy021C20]), suggesting that it may be important for establishing transcriptional patterning.

During differentiation, acquisition of H3K27ac at enhancers is associated with the formation of enhancer-promoter interactions and induction of their target genes ([@dmy021C203]; [@dmy021C169]). Knockout in mice of the H3K27 acetyltransferases CBP or p300 (which also acetylate other histone residues and interact with many transcription factors themselves) leads to mid-gestation embryonic lethality ([@dmy021C216]). Embryos suffer from neural tube defects and aberrant cell proliferation ([@dmy021C216]); surprisingly, this suggests that H3K27ac is not required for establishing the transcriptional programming during early lineage specification. This is consistent with the finding that the effect of histone acetylation on chromatin accessibility is rather subtle ([@dmy021C204]). Therefore, H3K27ac may act synergistically to increase chromatin accessibility at active regulatory elements, but likely is not sufficient to activate a locus.

Together these studies suggest that several epigenetic marks, in particular H3K27me3 and H3K4me3, are required for lineage specification, but for the most part it appears that epigenetic modifications may reinforce lineage commitment rather than direct it. As new single/low-cell molecular approaches are implemented to evaluate gene regulation and epigenetic patterning through this important developmental window, new insights into the molecular hierarchy of gene regulation may be revealed.

Dynamics of genomic imprinting during embryonic development {#dmy021s13}
-----------------------------------------------------------

As discussed above, a subset of genomic loci maintain gamete DNA methylation throughout epigenetic reprogramming in the embryo. These domains are termed germline differentially methylated regions (gDMRs) and their mono-allelic parent-of-origin DNA methylation persists through cell differentiation and into adulthood. GDMRs can regulate nearby genes, resulting in mono-allelic gene expression, termed genomic imprinting. In mice, there are 23 maternal and three paternal gDMRs regulating the gene expression of \~151 genes (<https://www.mousebook.org/imprinting-gene-list>). Collectively, imprinted genes are essential for development, as demonstrated by embryo manipulation experiments used to generate embryos with exclusively maternal or paternal genomes ([@dmy021C128]; [@dmy021C191]). These embryos showed severe developmental and placental defects and do not survive.

There has been extensive investigation into the mechanisms allowing gDMRs to evade the DNA methylation erasure in the pre-implantation embryo. Several essential proteins have been identified, including DNA-binding proteins (ZFP57, UHRF1), key interactors (TRIM28/KAP1) and histone binding proteins (PGC7/Stella) ([@dmy021C22]; [@dmy021C179]; [@dmy021C117]; [@dmy021C161]; [@dmy021C130]; [@dmy021C144]). These appear to assemble in a complex that facilitates recruitment of DNMT1 and the H3K9 methyltransferase SETDB1 and exclusion of DNA demethylation enzymes (TETs) at imprinted gDMRs ([@dmy021C129]).

A recent study has also shown that genomic imprinting can be conferred by another epigenetic mark in addition to DNA methylation: maternal H3K27me3 inherited from the oocyte ([@dmy021C95]). [@dmy021C95] identified several domains where the maternal allele was silenced by H3K27me3, thereby mediating paternal-specific gene expression. Intriguingly, this non-canonical form of imprinting was only able to be maintained in extra-embryonic lineages post-implantation ([@dmy021C95]), suggesting embryonic lineages effectively reprogram the parental bias at these domains.

Human development: how conserved are mechanisms between mouse and human? {#dmy021s14}
========================================================================

Using low-input and single-cell sequencing techniques, the first advances with human samples were made in recent years, allowing us to compare the transcriptome, methylome and chromatin accessibility of human gametes and early embryos with what is known from mouse models. Other technologies, such as Hi-C, are likely to follow soon, but current ChIP-seq methods still require at least one hundred cells, making progress with human oocytes and early cleavage stage embryos more challenging. So far, studies on human development have shown that, in general, DNA methylation patterns and reprogramming events are relatively conserved between mouse and human (Table [II](#dmy021TB2){ref-type="table"}). This supports the mouse as a model organism for elucidating general mechanisms of epigenetic reprogramming in early development. However, when looking in detail, differences can be observed, likely with functional consequences (Table [II](#dmy021TB2){ref-type="table"}). In the following sections, we highlight the known differences between human and mouse. Table IIComparative evaluation of epigenetic features and processes evaluated during human and mouse development to date.Tissue/cell typeEpigenetic feature/processMouseHumanReferenceRelative similarityPGCsDNA methylation erasureGlobal DNA methylation and imprinted DMRs are erased upon PGC specificationGlobal DNA methylation and imprinted DMRs are erased upon PGC specification[@dmy021C75], [@dmy021C176], [@dmy021C78], [@dmy021C71], [@dmy021C76]SpermDNA methylation patterns in sperm\~80% genome-wide methylation, with unmethylated regulatory domains\~75% genome-wide methylation, with unmethylated regulatory domains[@dmy021C150], [@dmy021C110], [@dmy021C80]*De novo* DNMTs in spermatogenesisDNMT3A, 3L and 3C are essential for spermatogenesisUnknown; DNMT3A, 3B and 1 are dynamically expressed during spermatogenesis, but there is no expression of DNMT3L and no orthologous gene for DNMT3C[@dmy021C24], [@dmy021C105], [@dmy021C14], [@dmy021C126]Retention of modified histones in sperm\~1% genome-wide, enriched at developmental promoters\~10% genome-wide, enriched at developmental promoters[@dmy021C29], [@dmy021C84]OocyteDNA methylation patterns in the oocyte\~40% genome-wide methylation and localised predominantly to expressed gene bodies\~54% genome-wide methylation and localised predominantly to gene bodies[@dmy021C151], [@dmy021C110]*De novo* DNMTs in oogenesisDNMT3A and 3L are essential for establishing DNA methylation in oocytesUnknown; in human oocytes, DNMT1, 3A and 3B are expressed, but not DNMT3L[@dmy021C24], [@dmy021C186], [@dmy021C181], [@dmy021C80], [@dmy021C151]Histone modification patternsNon-canonical distributions of both H3K4me3 and H3K27me3 across regions lacking DNA methylationUnknown[@dmy021C222], [@dmy021C45], [@dmy021C88], [@dmy021C224]Higher order chromatin organisationWeak TADs and loops and a loss of A/B compartments upon transcriptional silencingUnknown[@dmy021C61], [@dmy021C55], [@dmy021C106]Pre-implantation embryoDNA methylation dynamics in pre-implantation developmentActive loss of paternal methylation and passive loss of maternal methylation; regions of DNA methylation turnoverActive loss of paternal methylation and minimal passive loss of maternal methylation; regions of DNA methylation turnover[@dmy021C80], [@dmy021C151], [@dmy021C187], [@dmy021C226]ZFP57-mediated protection of imprinted DMRsMaternal/oocyte contribution of ZFP57 is required to protect imprints in pre-implantation developmentZFP57 is required to protect imprints, but it is not expressed in human oocytes; expression is initiated in the pre-implantation embryo[@dmy021C161], [@dmy021C117], [@dmy021C151], [@dmy021C122], [@dmy021C172]Chromatin configuration post-fertilisationWidespread open chromatin that resolves upon ZGAWidespread open chromatin that resolves upon ZGA[@dmy021C209], [@dmy021C210]Histone modification dynamicsNon-canonical maternal H3K4me3 resolves to canonical pattern, while maternal H3K27me3 is predominantly erasedUnknown[@dmy021C224], [@dmy021C222], [@dmy021C45]Higher order chromatin organisationCanonical patterns of TADs, loops, and A/B compartments restored during early embryogenesisUnknown[@dmy021C61], [@dmy021C106], [@dmy021C55]BlastocystDNA methylation patterns in blastocyst-stage embryosMaintenance of imprinted DMRs and low levels of oocyte methylation patternsMaintenance of imprinted DMRs and persistent oocyte methylation patterns[@dmy021C110], [@dmy021C151], [@dmy021C80], [@dmy021C226]Post-implantation embryonic tissuesNumber of imprinted genes\~125--151, with numerous imprinted gene clusters\~50--90, with numerous imprinted gene clusters[@dmy021C43], [@dmy021C10], [@dmy021C171], [@dmy021C173], [@dmy021C5]Epigenetic regulation of imprinted gene clustersNon-coding RNAs and differential DNA methylation regulate imprinted gene expressionNon-coding RNAs and differential DNA methylation regulate imprinted gene expressionReviewed in [@dmy021C162]X chromosome inactivation (XCI) in embryogenesisRandom XCI, mediated by opposing expression of *Xist* and *Tsix*Random XCI, mediated by expression of *XIST* from the inactive XReviewed in [@dmy021C65]Genetic polymorphisms influence imprinted gene expression*Cis*-acting strain-specific SNPs can influence allelic bias in imprinted gene expression*Cis*-acting SNPs can influence allelic bias in imprinted gene expression[@dmy021C43], [@dmy021C5], [@dmy021C10], [@dmy021C69]Tissue-specific imprinted gene expressionSeveral imprinted genes are tissue-specificSeveral imprinted genes are tissue-specific[@dmy021C43], [@dmy021C5], [@dmy021C10]Post-implantation extra-embryonic tissuesGenome-wide methylation patternsExtra-embryonic tissues are characterised by large partially methylated domainsExtra-embryonic tissues are characterised by large partially methylated domains[@dmy021C166], [@dmy021C175], [@dmy021C47]XCI in extra-embryonic tissuesImprinted inactivation of the paternal X chromosome, conferred by repression of maternal *Xist* by oocyte-derived H3K27me3Random XCI[@dmy021C194], [@dmy021C132], [@dmy021C156], [@dmy021C96]Abundance of placental-specific imprinted gDMRsNone reported\>1500 placental-specific gDMRs reported[@dmy021C87], [@dmy021C82], [@dmy021C171]Polymorphic imprinted DMRsUnknownPervasive in extra-embryonic tissues[@dmy021C87], [@dmy021C171]Non-canonical imprintingSeveral non-canonical placenta-specific imprinted genes mediated by maternal H3K27me3Unknown[@dmy021C95]Large placenta-specific imprinted domains: KvDMRDistal placental-specific imprinting of genes in the KvDMR locusWhile the canonical imprinting at KvDMR is conserved, distal genes are not imprinted in placenta[@dmy021C115]; [@dmy021C64]Large placenta-specific imprinted domains: Chromsome 19 micro-RNA clusterNo orthologous regionChromosome 19 micro-RNA cluster is imprinted specifically in placenta[@dmy021C147][^3]

Gametes {#dmy021s15}
-------

Similar to mice, human PGCs undergo almost complete erasure of DNA methylation during early embryonic development ([@dmy021C78], [@dmy021C76]; [@dmy021C71]). Given the difficulties in obtaining samples from late gestation foetal gonads and immature gametes, the resetting of DNA methylation during spermatogenesis and oogenesis remains unexplored. However, the DNA methylome of human mature gametes, gives us some insights into epigenetic programming events during gametogenesis.

There are substantial physiological differences between mammalian species during spermatogenesis ([@dmy021C56]), and yet, global epigenetic trends in mature sperm, such as DNA hyper-methylation in inter-genic regions and the histone-to-protamine exchange, are similar ([@dmy021C137]). However, some aspects of the *de-novo* DNA methylation mechanisms may differ between mouse and human. Recently, a novel DNA methyltransferase (DNMT3C) was discovered, specifically active at young transposable elements during mouse spermatogenesis ([@dmy021C14]). In male mice, this enzyme is crucial for fertility, but this gene is not present in the human genome. Furthermore, while DNMT3L is essential for spermatogenesis in mice ([@dmy021C24]), DNMT3L appears to not be expressed at any time during human spermatogenesis ([@dmy021C126]). While the replacement of histones by protamines is conserved, \~10-fold more nucleosomes appear to be retained in human sperm than in mouse sperm ([@dmy021C84]; [@dmy021C29]). Retained histones may therefore be more likely to permit paternal epigenetic regulation of transcription in the pre-implantation embryo ([@dmy021C35]; [@dmy021C134]), although this remains to be shown.

The first study to report DNA methylation patterns in human oocytes used RRBS, which mainly captures CpG islands and other CG-rich sequence and covers 5--10% of the genome ([@dmy021C80]). Since then, a genome-wide approach on pools of oocytes and two single-cell studies have been published, all together giving us a very comprehensive understanding of the human fully grown oocyte methylome ([@dmy021C151]; [@dmy021C217]; [@dmy021C226]). Human oocytes have a higher average DNA methylation level than mice (\~54% in humans versus \~40% in mice) (Data source: PRJDB18 and PRJDB4030) ([@dmy021C110]; [@dmy021C151]) (Fig. [4](#dmy021F4){ref-type="fig"}A). Despite the increase in fully methylated regions in human oocytes, it is still predominantly restricted to gene bodies (Fig. [4](#dmy021F4){ref-type="fig"}B). Indeed, a larger proportion of genes are methylated in human oocytes than in mouse (Fig. [4](#dmy021F4){ref-type="fig"}C); however, this is likely not due to an overall increase in transcription in human oocytes, as a similar number of transcripts were detected (FPKM\>1) (Data source: GSE44183) ([@dmy021C213]). These findings suggest either that DNMTs may be more active in human oocytes or that the relatively longer duration of oocyte maturation in humans compared to mouse (\~150 days vs. 21 days, respectively) permits more extensive accumulation of DNA methylation ([@dmy021C73]; [@dmy021C92]). Notably, DNMT3L, a co-factor of DNMT3A that is essential for *de-novo* methylation in mouse oocytes ([@dmy021C24]; [@dmy021C186]; [@dmy021C181]), is not expressed in human oocytes ([@dmy021C80]; [@dmy021C151]). It is currently unknown if DNMT3A can function independently in the human oocyte or if it is supported by other factors, like DNMT3B.

![Comparison of DNA methylation in human and mouse development. (**A**) Beanplots showing the distribution of DNA methylation percentages of 100-CpG running windows (minimum coverage of 10 CpGs) in human (top) and mouse (bottom) GV oocytes, sperm and blastocysts, with human oocytes and blastocysts being notably more methylated than mouse oocytes and blastocysts, respectively. (**B**) Screenshot of DNA methylation at the *KvDMR* imprinted locus in human (top) and mouse (bottom) GV oocytes, sperm and blastocysts. The locus illustrates the increased number of regions that are fully methylated in human compared to mouse oocytes. Additionally, the human blastocyst retains the maternal pattern of methylation more substantially than the mouse blastocyst. (**C**) Proportion of orthologous genes that are methylated in human and mouse oocytes. Orthologous genes were defined by ENSEMBL BioMart and categorised as highly expressed (FPKM\>10), intermediately expressed (1\<FPKM\<10) or lowly expressed (FPKM\<1). These genes were then evaluated for overlap with fully methylated (\>75%) and intermediately methylated (25--75%) 100-CpG windows; genes that did not overlap a methylated window were defined as unmethylated. This analysis demonstrates that the increase in methylated domains in human oocytes reflects an increased number of genes becoming fully methylated compared to mouse. Publically available data was used for these analyses, including RNA-seq data for mouse and human oocytes (GSE44183) ([@dmy021C213]) and DNA methylation data from mouse ([@dmy021C110]) and human ([@dmy021C151]) oocytes, sperm and blastocyst embryos.](dmy021f04){#dmy021F4}

From germ cells to the embryo {#dmy021s16}
-----------------------------

After fertilisation, there is global reprogramming of DNA methylation in the human pre-implantation embryo with lowest levels attained at the blastocyst stage ([@dmy021C80]; [@dmy021C151]; [@dmy021C187]; [@dmy021C226]). The paternal genome is actively demethylated first and more substantially, whereas the maternal genome shows maintenance of much of the oocyte-derived methylation ([@dmy021C80]; [@dmy021C151]; [@dmy021C226]). The retention of maternal methylation is considerably more substantial in the human than in the mouse, suggesting there is less passive demethylation and that perhaps DNMT1 has a more active role in the human pre-implantation embryo (Fig. [4](#dmy021F4){ref-type="fig"}A and B). As discussed in the section above, in mice, gDMRs are protected from passive demethylation by a complex including ZFP57 ([@dmy021C129]). Interestingly, unlike mice, ZFP57 is not expressed in human oocytes ([@dmy021C151]), but is still required for maintenance of imprinting during human development ([@dmy021C122]). Thus ZFP57 is required for maintaining imprinted gDMRs in both mouse and human, but the developmental stage for its requirement differs.

A profound difference between human and mouse during early pre-implantation development is the discrepancy in timing of ZGA. Whereas the mouse genome undergoes the major wave of ZGA at the 2-cell stage, in human embryos this occurs at the 8-cell stage ([@dmy021C26]; [@dmy021C8]). Despite these differences in timing, a recent study has shown that pre-ZGA embryos have widespread open chromatin in both mouse and human, and this unusual chromatin landscape is rapidly remodelled upon ZGA ([@dmy021C210]). Importantly, using an inhibitor of transcription (α-amanitin) in mouse and human embryos, they were able to show that this transition of chromatin accessibility was in fact dependent on transcriptional activation ([@dmy021C210]). The widespread open chromatin pattern in transcriptionally silent mouse zygotes has been shown to be linked to non-canonical patterning of H3K4me3 in the oocyte ([@dmy021C45]; [@dmy021C4]; [@dmy021C222]), and while ChIP-seq data is currently unavailable for human embryos, one can speculate that similar mechanisms may be involved.

In pre-implantation development, there are notable differences in the transcriptome of mouse and human embryos ([@dmy021C213]; [@dmy021C214]; [@dmy021C19]). Although similar transcription factors appear to function in mouse and human pre-implantation embryos, the temporal regulation and the transcriptional networks they regulate can differ, suggesting there are divergent aspects of early development ([@dmy021C19]; [@dmy021C62]; [@dmy021C210]). It is not clear yet if the epigenome may be instructive for some of these transcriptional differences. However, one study found that there was an increasing correlation between transcription and promoter methylation from the zygotic stage to post-implantation, especially after ZGA, in the human embryo ([@dmy021C80]). This suggests that the retention of maternal DNA methylation in the human embryo may play a role.

Initially, pre-implantation development was thought to be exclusively a time of DNA methylation erasure ([@dmy021C188]); however, recent studies in mouse and human show that there is *de-novo* methylation during pre-implantation development ([@dmy021C3]; [@dmy021C226]). Thus far, this phenomenon has been best described in human development. Zhu and colleagues found two phases of *de-novo* methylation: first, the paternal genome in the zygote between the early- to mid-pronuclear stage, just after a major wave of active demethylation; second, between the 4- and 8-cell stage coinciding with ZGA. Regions gaining methylation are enriched in repetitive elements, especially evolutionary younger classes of SINEs and LINEs. The targeting of *de-novo* methylation to potentially more active repeat elements has been suggested to repress their transcriptional activity to avoid mobilisation and safeguard genome stability during ZGA ([@dmy021C187]). However, methylation of these regions was surprisingly transient, as they became demethylated again in the following developmental stages ([@dmy021C226]). These findings highlight the unexpectedly complex methylation dynamics in the early embryo.

Post-implantation development {#dmy021s17}
-----------------------------

The epigenetic regulation of lineage specification in the post-implantation embryo is largely unexplored in humans due to challenges in obtaining samples. Our current knowledge of epigenetics in post-implantation development is largely extrapolated from human embryonic stem cell differentiation systems, which have provided important insights into tissue differentiation, as discussed elsewhere ([@dmy021C212]). However, recent advances of *in-vitro* culture of human embryos have enlivened the ethical discussion about embryo culture past the implantation-stage blastocyst ([@dmy021C206]; [@dmy021C178]), and may eventually allow the study of epigenetics in post-implantation development *in vivo*.

Genomic imprinting {#dmy021s18}
------------------

The majority of imprinted gene clusters identified in mouse are conserved in their methylation status, allelic expression and synteny in humans, although with several notable exceptions ([@dmy021C162]). There has been considerable work identifying novel imprinted genes in humans, using a combination of sequencing approaches over single nucleotide polymorphisms (SNPs) ([@dmy021C131]; [@dmy021C10]; [@dmy021C82]; [@dmy021C173]) or cases with genomic imbalances ([@dmy021C37]; [@dmy021C218]; [@dmy021C110]; [@dmy021C42]; [@dmy021C87]; [@dmy021C171]). These studies have estimated there are 50--90 imprinted genes in humans; however, many more DMRs have been identified, but whether these are all regulating gene expression remains unclear. The task of identifying an exhaustive list of imprinted loci in healthy tissues has proven challenging, due to the limited frequency and availability of parental information for SNPs in human populations ([@dmy021C131]; [@dmy021C82]; [@dmy021C173]), and the pervasive tissue-specific and polymorphic imprinting ([@dmy021C10]; [@dmy021C87]). Overall, findings suggest that imprinted gene expression and methylation may be more widespread and variable in humans than in mice; however, as similar screens are now being implemented in mice ([@dmy021C10]; [@dmy021C43]; [@dmy021C5]), comparable patterns may emerge.

As discussed in section above, the genome-wide methylation profiles in human and mouse gametes are remarkably similar. This is notable considering that the repertoire of DNMTs responsible for these patterns are not identical. In the foetus and adult, human imprinted genes are similarly regulated by gDMRs that are maintained through early development, yet to date very little is known about how imprints are protected during human reprogramming. Foremost, the maintenance of imprinted gDMRs in the human pre-ZGA embryo appears to be independent of ZFP57 ([@dmy021C151]). However, mutations in *ZFP57* cause 50% of cases with transient neonatal diabetes with loss of imprinting at multiple loci, termed a multilocus imprinting disorder (MLID) ([@dmy021C172]), supporting that ZFP57 is required during later stages. Several research groups have sought to identify genetic mutations associated with MLID to identify novel regulators in imprinting in humans; surprisingly, very few genes have been identified ([@dmy021C172]). In addition to *ZFP57*, maternal effect genes *NLRP5*, *KHDC3L* and primate-specific *NLRP7* are associated with loss of imprinting ([@dmy021C141]; [@dmy021C155]; [@dmy021C51]). However, these encode cytoplasmic proteins and are thought to be components of the subcortical maternal complex. Therefore, they may be involved in controlling the intracellular localisation of epigenetic regulators in the oocyte or zygote, rather than having a direct role in imprinting ([@dmy021C138]). Together, these findings suggest that the protection of DNA methylation at imprinted gDMRs is required in both mouse and human, but at least some of the epigenetic modifiers may have evolved distinct roles between species.

Recent studies have shown that imprinted gDMRs are far more pervasive in the human placenta than in foetal and adult tissues ([@dmy021C82]; [@dmy021C87]; [@dmy021C171]). The number of placental-specific imprinted gDMRs is reported to be upwards of 1500, and intriguingly all of these appear to inherit methylation from the oocyte ([@dmy021C82]). The role of these placental-specific DMRs is still under debate, as many are not associated with genes expressed in the placenta. These domains may therefore be recently evolved imprinted sites ([@dmy021C85]), as the vast majority are not conserved between mouse and human ([@dmy021C187]; [@dmy021C87]). In mouse, placental-specific imprinting appears to be largely conferred by non-canonical repression by maternal H3K27me3 ([@dmy021C114]; [@dmy021C95]), and yet, to date, it is unknown whether humans have this form of non-canonical imprinting.

Wider implications for human disease and fertility {#dmy021s19}
==================================================

Recent advances have allowed us to gain the first insights into epigenetic regulation of development, which will be essential in furthering our understanding of the role of epigenetics in human infertility, maternal and foetal health, and complications of pregnancy. As this field develops, it will also become clear whether epigenetic patterns established during prenatal development may influence the lifelong health of offspring and, additionally, whether early epigenetic reprogramming events are susceptible to perturbation by environmental exposures (toxins), physiological factors (stress, diet), or medical interventions (assisted reproductive technologies, ART). In this section, we will provide an overview of the recent developments and future directions in these areas of research.

Infertility {#dmy021s20}
-----------

Evidence from association studies support that aberrant epigenetic programming in sperm may contribute to male infertility. Several studies have found an association between increased histone retention and low sperm count or infertility ([@dmy021C7]; [@dmy021C198]; [@dmy021C68]; [@dmy021C83]; [@dmy021C48]). Additionally, aberrant sperm DNA methylation patterns has also been associated with semen parameters and male infertility ([@dmy021C139]; [@dmy021C200]). Furthermore, sequence variants in *DNMT3B* and *DNMT1* have been associated with male infertility ([@dmy021C195]) and variants in *DNMT3L* have been associated with abnormal sperm methylation ([@dmy021C109]).

The role of epigenetics in female infertility has not been evaluated directly due to the invasive procedures required for obtaining oocytes from women. However, there are examples of mutations or genetic anomalies that demonstrate the necessity of oocyte methylation in obtaining a healthy pregnancy ([@dmy021C197]). Women homozygous for mutations in *NLRP7*, *NLRP5* or *KHDC3L* have pregnancies with a loss of all or some maternal imprints, resulting in recurrent biparental hydatidiform molar pregnancies that miscarry early in development ([@dmy021C141]; [@dmy021C155]; [@dmy021C51]). Furthermore, cases of complete hydatidiform molar pregnancies, in which there is only a paternal genetic contribution, result in no embryo and abnormal placental development ([@dmy021C104]). Finally, unexplained miscarriage has been associated with defects in imprinted DNA methylation in foetal or placental samples ([@dmy021C86]; [@dmy021C158]; [@dmy021C225]), which may be a failure to establish imprints or to maintain them. Together, these findings support that gametic epigenetic defects contribute to human infertility and early pregnancy loss; however, the extent to which these changes may be causal in unexplained infertility or subfertility remains unclear.

Pregnancy complications {#dmy021s21}
-----------------------

Imprinting syndromes are extensively studied developmental epigenetic disorders ([@dmy021C157]). Loss of allele-specific gene expression at specific imprinted loci can result in developmental defects of varying severity, often involving aberrant foetal growth (reviewed elsewhere; [@dmy021C98]). The role of imprinted genes in foetal growth and placentation ([@dmy021C16]) has led to the suggestion that more subtle deregulation of imprinting may contribute to pregnancy complications, such as pre-eclampsia, and/or foetal growth restriction ([@dmy021C63]; [@dmy021C140]). However, despite extensive study, many associations remain inconclusive ([@dmy021C111]).

The establishment or modulation of post-implantation tissue-specific epigenetic patterns, in particular DNA methylation, have also been widely investigated for association with pregnancy complications. Studies have focused on placental biopsies because of the non-invasive means of obtaining these samples from healthy and pathological pregnancies, as well as the biological relevance ([@dmy021C99]; [@dmy021C164]). While many DNA methylation changes have been identified, studies have often been performed on whole placental villi, which can obscure the interpretation of these changes due to cell heterogeneity that may exist between patient groups ([@dmy021C99]). Additionally, DNA methylation changes may be a cause or a consequence of poor placental and/or foetal development. Therefore, an optimised study design will be required to determine whether epigenetic variation can predispose to adverse pregnancy outcomes and, furthermore, whether these changes mediate environmental influences.

Environmental and physiological influences on epigenetic reprogramming events {#dmy021s22}
-----------------------------------------------------------------------------

The Developmental Origins of Health and Disease (DoHaD) hypothesis posits that adaptive and maladaptive changes during foetal development in response to environmental exposures can result in predisposition to disease in adulthood ([@dmy021C202]). A well-known example of this is the severe prenatal caloric restriction that took place during the Dutch famine, which resulted in increased risk for obesity and comorbidities late in life ([@dmy021C165]). It has been suggested that DoHaD effects could be mediated by epigenetic programming in response to these environmental cues.

Investigations into the effects of maternal diet, smoking and stress on DNA methylation in offspring support this idea ([@dmy021C102]; [@dmy021C53]; [@dmy021C148]; [@dmy021C112]; [@dmy021C154]; [@dmy021C70]), while other investigations, such as studies of maternal alcohol consumption, have found no association ([@dmy021C180]). A particularly compelling example, is the evaluation of maternal diet on foetal DNA methylation in Gambian rural communities. These populations experience profound seasonal fluctuations in nutrient and micro-nutrient availability, and it was found that maternal nutrient status was predictive of DNA methylation patterns of so-called metastable epialleles (genomic loci whose methylation varies between individuals in the absence of genetic variants), including the imprinted gene *VTRNA2-1* ([@dmy021C53]). A challenge for many studies is the interpretation of observed methylation changes, as they are often subtle differences and at only a few CpG sites. Therefore, complementary studies in mouse models are essential to evaluate whether DNA methylation changes due to *in-utero* environmental exposures can influence gene expression patterns and developmental progression ([@dmy021C205]).

Additional evidence that early epigenetic programming is susceptible to environmental factors comes from the study of pregnancy outcomes associated with ART. With the increase in ART use globally, there has been an extensive effort to evaluate whether procedures, such as ovarian stimulation, *in-vitro* fertilisation (IVF), intra-cytoplasmic sperm injection (ICSI) and *in-vitro* culture, may increase the risk of developmental epigenetic defects ([@dmy021C33]). ART procedures have been reproducibly associated with increased risk of imprinting syndromes in human epidemiology studies, although the prevalence is still extremely low ([@dmy021C93]; [@dmy021C207]). Studies directly evaluating epigenetic patterns in ART-generated human embryos are scarce and since *in-vivo* samples as a comparison group are inaccessible, results can be difficult to interpret. Nevertheless, targeted assessment of imprinted gDMRs in human cultured embryos has shown that aberrant imprinting could be present in \>50% ([@dmy021C207]). It remains contentious whether ART is associated with additional pregnancy complications or long-term consequences for offspring health ([@dmy021C46]; [@dmy021C89]; [@dmy021C120]; [@dmy021C60]), and whether these may be due to developmental epigenetic changes remains to be explored.

Concluding remarks {#dmy021s23}
==================

The recent advances in low-input technologies has provided novel insights into epigenetic dynamics during oogenesis and the earliest events of embryonic development in mice. Studies to date have revealed the unique epigenetic landscape of the oocyte, not only DNA methylation, but also histone modifications and nuclear organisation. Future work will continue to explore the underlying mechanisms and the functional importance of these non-canonical patterns. The evaluation of epigenetic profiles in the early embryo suggest that there is widespread erasure of gametic epigenetic patterns after fertilisation and subsequent re-establishment of DNA methylation, histone modifications, chromatin accessibility and nuclear organisation. While the mechanisms driving this reprogramming are unclear, it is apparent that there are localised exceptions, including both canonical and non-canonical imprinted regions.

At present, the study of epigenetic reprogramming events in humans has been largely restricted to DNA methylation. In comparison to mice, there appear to be similar dynamics in both gametes and the early embryo, and yet the proteins modulating these dynamics are often divergent in timing or function. Thus, future investigations of epigenetic patterns in human development may not only reveal further novel regulatory mechanisms, but also differences in the extent of epigenetic information transmitted from gametes to embryos. These discoveries will be essential in understanding the influence of our environment on pregnancy and lifelong health of offspring.
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